EUVIMEDEUVIMED entdecken
Leitlinie

Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019)

Natalia L Laufer, María B Bouzas, Silvina Fernández Giuliano, Ines Zapiola, Lilia Mammana, Horacio Salomon, Cecilia Monzani, Gonzalo Castro, Maria Laura Suarez Ornani, Paula Rojas Machado, Natalia Cochon, Ariel Adazsko und 6 weitere

AIDS Research and Human Retroviruses · 2024

DOI: 10.1089/aid.2023.0083 ↗

Kurz gefasst

Leitlinie in der Zeitschrift AIDS Research and Human Retroviruses, 2024. Verfasst von Natalia L Laufer und 17 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Drug Resistance, Viral, HIV-1, HIV Infections, World Health Organization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, ViralHIV-1HIV InfectionsWorld Health OrganizationHumansArgentinaMaleCross-Sectional StudiesFemaleAdultMiddle AgedPrevalenceYoung AdultAdolescentAnti-HIV AgentsMutationReverse Transcriptase InhibitorsAged

Stichwörter der Autor:innen

HIVHIV epidemiologyHIV resistanceHIV subtype

Substanzen

Anti-HIV AgentsReverse Transcriptase Inhibitors

Autor:innen und Institutionen

  • Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Hospital Muñiz, Ciudad de Buenos Aires, Argentina.
  • Laboratorio Central de Córdoba, Ciudad de Córdoba, Argentina.
  • Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina.
  • Pan American Health Organization, Washington, District of Columbia, USA.
  • Pan American Health Organization, Ciudad de Buenos Aires, Argentina.

ORCID-Profile: Sergio Martini

Zitieren

APA

Laufer, N. L., Bouzas, M. B., Fernández Giuliano, S., Zapiola, I., Mammana, L., Salomon, H., Monzani, C., Castro, G., Suarez Ornani, M. L., Rojas Machado, P., Cochon, N., Adazsko, A., Ravasi, G., Vila, M., Maulen, S., Ceriotto, M., Barbas, M. G., & Martini, S. (2024). Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019). AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2023.0083

Vancouver

Laufer NL, Bouzas MB, Fernández Giuliano S, Zapiola I, Mammana L, Salomon H, et al. Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019). AIDS Research and Human Retroviruses. 2024. doi:10.1089/aid.2023.0083

BibTeX
@article{Laufer2024,
  author = {Laufer, Natalia L and Bouzas, María B and Fernández Giuliano, Silvina and Zapiola, Ines and Mammana, Lilia and Salomon, Horacio and Monzani, Cecilia and Castro, Gonzalo and Suarez Ornani, Maria Laura and Rojas Machado, Paula and Cochon, Natalia and Adazsko, Ariel and Ravasi, Giovanni and Vila, Marcelo and Maulen, Sergio and Ceriotto, Mariana and Barbas, María Gabriela and Martini, Sergio},
  title = {Pretreatment HIV-1 Resistance in Argentina: Results from the Second Surveillance Study Following World Health Organization Guidelines (2019)},
  journal = {AIDS Research and Human Retroviruses},
  year = {2024},
  doi = {10.1089/aid.2023.0083}
}
Kostenlos starten →